Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

The effects of quinpirole and fenoldopam on the potassium-evoked overflow of endogenous dopamine and noradrenaline in dog mesenteric arteries

Summary

(1) Dopamine and noradrenaline overflow from the main trunk of the dog mesenteric artery and its proximal branches, elicited by K+ (52 mmol/l), was measured by high pressure liquid chromatography with electrochemical detection. (2) Quinpirole (0.1, 1 and 10 nmol/l) produced a concentration dependent reduction of dopamine and noradrenaline overflow in both segments of the mesenteric artery. The inhibitory effect of quinpirole (10 nmol/l) on amine overflow was antagonized by sulpiride (1 μmol/l) but not by phentolamine (0.2 μmol/l) or the selective dopamine (DA1), antagonist SK&F 83566 (1 μol/l). (3) Fenoldopam (0.1 and 1 μmol/l) did not alter dopamine and noradrenaline overflow from both segments of the mesenteric artery; only 10 μmol/l fenoldopam was found to increase the overflow of dopamine and noradrenaline in both segments of the mesenteric artery. This effect of fenoldopam on amine overflow was not altered by the addition to the perifusion fluid of SK&F 83566 (1 μol/l). (4) Clonidine (100 nmol/l) significantly reduced amine overflow from both segments of the mesenteric artery and this effect was antagonized by fenoldopam (10 μmol/l) (5) These results suggest that quinpirole inhibits sympathetic neurotransmission through the activation of prejunctional dopamine receptors of the DA2 subtype. The facilitatory effect of fenoldopam (10 μmol/l) on amine release appears to be mediated through the blockade of prejunctional α2-adrenoceptors.

This is a preview of subscription content, log in to check access.

References

  1. Azevedo I, Soares-da-Silva P (1981) Are fibroblasts adrenergically inervated cells? Blood Vessels 18:330–332

  2. Berkowitz BA, Zabko-Potapovich B, Sherman S, Hieble JP, Weinstock J, Ohlstein EH (1984) Vascular effects of SK&F 83566: a selective dopamine (DA-1) receptor antagonist. Fed Proc 43:743

  3. Berkowitz BA, Sherman S, Ohlstein EH (1985) Utility and selectivity of vascular dopamine (DA-1) receptor antagonists. In: Bevan JA, Godfraind T, Maxwell RA, Stoclet JC, Worcel M (eds) Vascular Neuroeffector Mechanisms: 5th International Symposium. Elsevier, Oxford, pp 227–234

  4. Bevan JA (1978) Norepinephrine and the presynaptic control of adrenergic transmitter release. Fed Proc 37:187–190

  5. Brodde O-E (1982) Vascular dopamine receptors: Demonstration and characterization by in vitro studies. Life Sci 31:289–306

  6. Dupont AG, Lefebvre RA, Vanderniepen P (1987) Influence of the dopamine agonists fenoldopam and quinpirole in the rat superior mesenteric superior vascular bed. Br J Pharmacol 91:493–501

  7. Foley JJ, Saran HM (1984) Adrenergic binding studies of SK&F 82526 and its enantiomers. Fed Proc 43:555

  8. Goldberg LI, Volkman PH, Kohli JD (1978) A comparison of the vascular dopamine receptor with other dopamine receptors. Ann Rev Pharmacol Toxicol 18:57–79

  9. Hahn RA, Wardell JR, Saran HM, Ridley PT (1982) Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist. J Pharmacol Exp Ther 223:305–313

  10. Hilditch A, Drew GM (1985) Peripheral dopamine receptor subtypes — a closer look. Trends Pharmacol Sci 6: 396–400

  11. Kohli JD, Glock D, Goldberg LI (1988) Relative DA1-receptor agonist and a-adrenoceptor antagonistic activity of fenoldopam in the anesthetized dog. J Cardiovasc Pharmacol 11:123–126

  12. Langer SZ (1981) Presynaptic regulation of the release of catecholamines. Pharmacol Rev 32:337–362

  13. Langer SZ, Vidal M, Duval N (1987) Presynaptic dopamine receptors in the cardiovascular system. Clin Exp Hypertension A9:837–851

  14. Lokhandwala MF, Barrett RJ (1982) Cardiovascular dopamine receptors: Physiological, pharmacological and therapeutic implications. J Anton Pharmacol 3:189–215

  15. Lokhandwala MF, Steenberg ML (1984) Evaluation of the effects of SK&F 82526 and LY 171555 on presynaptic DA2 and postsynaptic (DAj) dopamine receptors in rat kidney. J Anton Pharmacol 4:273- 277

  16. Ohlstein EH, Zabko-Potapovich B, Berkowitz BA (1984) Studies on vascular dopamine receptors with the dopamine receptor agonist: SK&F 82526. J Pharmacol Exp Ther 229:433–439

  17. Ohlstein EH, Zabko-Potapovich B, Berkowitz BA (1985) The DA1-receptor agonist fenoldopam (SK&F 82526) is also an α2-adrenoceptor antagonist. Eur J Pharmacol 118:321–329

  18. Sengupta S, Lokhandwala MF (1985) Characterization of the hypotensive action of dopamine receptor agonists fenoldopam and quinpirole in anesthetized rats. J Anton Pharmacol 5:289–294

  19. Shebuski RJ, Fujita T, Smith JM, Kopaciewicz LJ, Blumberg AL, Hieble JP (1985) Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog. J Pharmacol Exp Ther 235:735–740

  20. Soares-da-Silva P (1986) Evidence for a non-precursor dopamine pool in noradrenergic neurones of the dog mesenteric artery. Naunyn-Schmiedeberg's Arch Pharmacol 333:219–223

  21. Soares-da-Silva P (1987a) A comparison between the pattern of dopamine and noradrenaline release from sympathetic neurones of the dog mesenteric artery. Br J Pharmacol 90: 91–98

  22. Soares-da-Silva P (1987b) Dopamine released from nerve terminals activates prejunctional dopamine receptors in dog mesenteric arterial vessels. Br J Pharmacol 91:591–599

  23. Soares-da-Silva P (1988a) Dopamine and noradrenergic transmission. In: Vanhoutte PM (ed) Mechanisms of Vasodilatation. Raven Press, New York, pp 187–195

  24. Soares-da-Silva P (1988b) Evidence for dopaminergic co-transmission in dog mesenteric arterial vessels. Br J Pharmacol 95:218–224

  25. Soares-da-Silva P, Azevedo I (1985) Fibroblasts and sympathetic innervation of blood vessels. Blood Vessels 22: 278–285

  26. Soares-da-Silva P, Davidson R (1985) Effects of 6-hydroxydopamine on dopamine and noradrenaline content in dog blood vessels and heart. Evidence for a noradrenaline-independent dopamine pool. Nauny-Schmiedeberg's Arch Pharmacol 329:253–257

  27. Sokal RR, Rohlf FJ (1981) Biometry. The principles and practice of statistics in biological research. Freeman and Company, New York

  28. Starke K (1977) Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 77:1–124

  29. Starke K (1987) Presynaptic a-autoreceptors. Rev Physiol Biochem Pharmacol 107:73–146

  30. Szabo B, Hedler L, Starke K (1986) Dopamine, receptor agonist and alpha-2 adrenoceptor antagonist effects of fenoldopam in rabbits. J Pharmacol Exp Ther 239: 881–886

  31. Willems JL, Buylaert WA, Lefevbre RA, Bogaert MJ (1985) Neuronal dopamine receptors on autonomic ganglia and sympathetic nerves and dopamine receptors in the gastrointestinal system. Pharmacol Rev 37:165–215

Download references

Author information

Additional information

Send offprint requests to P. Soares-da-Silva at the above address

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Soares-da-Silva, P. The effects of quinpirole and fenoldopam on the potassium-evoked overflow of endogenous dopamine and noradrenaline in dog mesenteric arteries. Naunyn-Schmiedeberg's Arch Pharmacol 341, 37–42 (1990). https://doi.org/10.1007/BF00195055

Download citation

Key words

  • Dopamine release
  • Noradrenaline release
  • DA2-receptors
  • Quinpirole
  • Fenoldopam